KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Gross Margin (2019 - 2025)

Historic Gross Margin for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to 57.39%.

  • GoodRx Holdings' Gross Margin rose 34100.0% to 57.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 56.69%, marking a year-over-year increase of 31300.0%. This contributed to the annual value of 53.67% for FY2024, which is 8400.0% down from last year.
  • Per GoodRx Holdings' latest filing, its Gross Margin stood at 57.39% for Q3 2025, which was up 34100.0% from 58.21% recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Gross Margin registered a high of 59.17% during Q2 2023, and its lowest value of 49.09% during Q3 2023.
  • In the last 5 years, GoodRx Holdings' Gross Margin had a median value of 53.97% in 2024 and averaged 53.75%.
  • As far as peak fluctuations go, GoodRx Holdings' Gross Margin crashed by -79300bps in 2021, and later soared by 83600bps in 2023.
  • GoodRx Holdings' Gross Margin (Quarter) stood at 50.06% in 2021, then grew by 8bps to 54.31% in 2022, then fell by -4bps to 52.32% in 2023, then grew by 1bps to 52.75% in 2024, then grew by 9bps to 57.39% in 2025.
  • Its Gross Margin was 57.39% in Q3 2025, compared to 58.21% in Q2 2025 and 58.35% in Q1 2025.